Protease Inhibitor

As per available reports many journals, Conferences, workshops are presently dedicated exclusively to Protease Inhibitor and articles are being published on the current trends in Protease Inhibitor. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Protease Inhibitor are being carried out. As reported in Wikipedia, Protease inhibitors are a class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis caused by hepatitis C virus. Protease inhibitors prevent viral replication by selectively binding to viral proteases (e.g. HIV-1 protease) and blocking proteolytic cleavage of protein precursors that are necessary for the production of infectious viral particles. Protease inhibitors can cause a syndrome of lipodystrophy, hyperlipidaemia, diabetes mellitus type 2, and kidney stones The Journal of Proteomics & Bioinformatics is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in proteomics. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Proteomics & Bioinformatics provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of proteomics and bioinformatics, thus bridging the gap between researchers and young scientists. OMICS International – a pioneer in organizing international conferences. Proteomics Studies give the broad info on Proteomics & Genomics like how genes and proteins are originated and their structure, along with Gene expression. While going into deep studies many investigators still view Genome Annotation as a notoriously unreliable and inaccurate process.